Development of Biomarkers and Prognosis Model of Mortality Risk in Patients with COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Biomarkers and Prognosis Model of Mortality Risk in Patients with COVID-19

Published:2024-04 Issue: Volume:Volume 17 Page:2445-2457
ISSN:1178-7031
Container-title:Journal of Inflammation Research
language:en
Short-container-title:JIR

Author:

Zhang Zhishuo,Tang Lujia^ORCID,Guo Yiran,Guo Xin^ORCID,Pan Zhiying,Ji Xiaojing,Gao Chengjin^ORCID

Publisher

Informa UK Limited

Reference35 articles.

1. China's COVID-19 reopening measures—warriors and weapons

2. The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease

3. How do routine laboratory tests change in coronavirus disease 2019?

4. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?

5. Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3